Journal of the American Psychiatric Nurses Association

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Phillips McEnany, G.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of the American Psychiatric Nurses Association, Vol. 13, No. 5 suppl, S6-S15 (2007)
DOI: 10.1177/1078390307304078
© 2007 American Psychiatric Nurses Association

Psychopharmacologic Strategies and Associated Challenges in the Long-Term Treatment of Schizophrenia

Geoffry Phillips McEnany

Department of Nursing, School and Health and Environment, University of Massachusetts Lowell; e-mail: remnrem{at}comcast.net

The comprehensive treatment of persons who have been diagnosed with schizophrenia requires the application of an effective and tolerable pharmacologic treatment regimen in conjunction with psychosocial interventions. The mainstay of pharmacologic treatment of persons diagnosed with schizophrenia is antipsychotic medication. The most commonly prescribed are the atypical or second-generation antipsychotic medications that have efficacy that matches, or in many cases is superior to that of conventional antipsychotics. In practice, however, medication adherence, as much as medication efficacy, is the key to improving patient outcomes. J Am Psychiatr Nurses Assoc, 2007; 13(S5), S6.-S15. DOI: 10.1177/1078390307304078

Key Words: schizophrenia • antipsychotic drugs • long-term treatment • adherence • relapse • prevention


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?